Granulocyte-Colony Stimulating Factor Use and Medical Costs after Initial Adjuvant Chemotherapy in Older Patients with Early-Stage Breast Cancer

By Griffiths Robert I.   Barron Richard L.  

PharmacoEconomics, Vol. 30, Iss. 2, 2012-02 ,pp. : 103-118

Adis International

Access to resources Recommend Favorite

Pilot study of adjuvant chemotherapy with 3-week combination of S-1 and cisplatin for patients with stage II-IV (M0) gastric cancer

By Kang Byung  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1671-1675

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer

By Kumar Aalok   Kennecke Hagen F.   Renouf Daniel J.   Lim Howard J.   Gill Sharlene   Woods Ryan   Speers Caroline   Cheung Winson Y.  

Cancer, Vol. 121, Iss. 4, 2015-02 ,pp. : 527-534

Blackwell Publishing

Access to resources Recommend Favorite

Adjuvant radiotherapy and lymph node dissection in pancreatic cancer treated with surgery and chemotherapy

By Mellon Eric A.   Springett Gregory M.   Hoffe Sarah E.   Hodul Pamela   Malafa Mokenge P.   Meredith Kenneth L.   Fulp William J.   Zhao Xiuhua   Shridhar Ravi  

Cancer, Vol. 120, Iss. 8, 2014-04 ,pp. : 1171-1177

Blackwell Publishing

Access to resources Recommend Favorite

Advanced-Stage Follicular Lymphoma in the Rituximab Era: When Should Patients Receive Anthracycline-Based Chemotherapy?

By Pettengell Ruth  

Drugs, Vol. 69, Iss. 13, 2009-09 ,pp. : 1727-1737

Adis International

Access to resources Recommend Favorite